Home > Healthcare > Medical Devices > Diagnostic Devices > D-dimer Testing Market
D-dimer Testing Market Size
- Report ID: GMI5972
- Published Date: Jun 2023
- Report Format: PDF
D-dimer Testing Market Size
D-Dimer Testing Market size was valued at over USD 1 billion in 2022 and is projected to reach more than USD 2 billion by 2032. D-dimer testing is a laboratory test used to detect the presence of D-dimer in the blood. D-dimer is a small protein fragment that is produced when a blood clot is dissolved in the body. It is considered a fibrin degradation product.
Additionally, the growing prevalence of blood clotting related genetic disorders is accelerating market growth. Genetic disorders that increase the risk of blood clot formation are uncommon but can have serious health implications. For instance, protein C and protein S deficiencies are rare, with estimated frequencies of around 1 in 300 to 500 individuals for protein C deficiency and 1 in 20,000 to 25,000 individuals for protein S deficiency.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| D-dimer Testing Market Size in 2022: | USD 1.2 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 4.3% |
| 2032 Value Projection: | USD 1.9 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 200 |
| Tables, Charts & Figures: | 279 |
| Segments covered: | Testing Method, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Moreover, increasing demand for next-generation point-of-care (POC) D-dimer tests. POC D-dimer tests enable healthcare providers to immediately rule out or confirm the presence of a thrombotic event, guiding further diagnostic evaluations or treatment plans. Rapid decision-making can lead to more efficient patient management, potentially reducing unnecessary imaging procedures, hospital admissions, and associated costs, thereby augmenting market expansion.
Frequently Asked Questions (FAQ) :
D-dimer Testing Market Scope
